| Breakdown | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 660.00M | 588.30M | 564.60M | 581.10M | 377.20M |
| Gross Profit | 318.90M | 279.50M | 262.60M | 262.70M | 222.80M |
| EBITDA | 104.50M | -40.50M | 67.70M | -188.90M | 46.80M |
| Net Income | 13.80M | -164.90M | -113.00M | -259.20M | -28.00M |
Balance Sheet | |||||
| Total Assets | 1.28B | 1.59B | 1.88B | 1.98B | 2.30B |
| Cash, Cash Equivalents and Short-Term Investments | 258.00M | 141.60M | 262.80M | 239.30M | 336.90M |
| Total Debt | 651.40M | 689.90M | 824.40M | 895.50M | 934.60M |
| Total Liabilities | 1.21B | 1.53B | 1.66B | 1.61B | 1.65B |
| Stockholders Equity | 69.70M | 57.70M | 223.50M | 369.50M | 652.90M |
Cash Flow | |||||
| Free Cash Flow | 100.90M | 93.10M | 57.00M | -34.70M | 27.60M |
| Operating Cash Flow | 117.00M | 113.20M | 83.70M | -13.90M | 46.50M |
| Investing Cash Flow | 6.10M | 14.80M | 18.00M | 4.10M | -27.30M |
| Financing Cash Flow | -69.50M | -144.50M | -73.80M | -54.20M | 69.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.44B | 6.98 | 11.24% | 11.03% | 2.58% | -12.71% | |
75 Outperform | £371.31M | 8.52 | 11.29% | 4.89% | -10.30% | 6.15% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £853.35M | 53.66 | -15.72% | ― | 12.19% | ― | |
65 Neutral | £1.44B | 5.39 | 12.75% | 4.74% | -4.98% | 3.02% | |
60 Neutral | £18.96B | 18.92 | 10.20% | 6.03% | 43.20% | 19.23% | |
53 Neutral | £705.55M | -59.40 | -2.93% | 8.03% | -40.13% | -369.64% |